What is Safe N Simple?
Safe N Simple operates as a specialized provider of high-quality medical products, focusing primarily on the ostomy, wound care, and urology segments. The company distinguishes itself through a comprehensive product ecosystem that emphasizes hygiene, ease of use, and patient-centric support. Beyond its core product offerings, the organization provides critical educational resources and the Simple Start Program, which facilitates seamless onboarding for new users. Furthermore, Safe N Simple maintains a versatile business model that includes private labeling and distributor programs, allowing the company to integrate deeply into the broader healthcare supply chain and serve a diverse range of clinical and individual needs.
How much funding has Safe N Simple raised?
Safe N Simple has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Safe N Simple
PPP
Public-Private Partnership
What's next for Safe N Simple?
With the infusion of this recent capital, Safe N Simple is expected to prioritize the scaling of its distribution networks and the enhancement of its private labeling capabilities. The strategic focus will likely shift toward optimizing supply chain efficiencies and expanding the reach of its educational initiatives to capture a larger share of the chronic care market. As the company matures, the integration of advanced logistics and potential product line diversification will be essential to maintaining its competitive edge. This late-stage financing provides the necessary liquidity to pursue aggressive growth strategies, potentially including partnerships with larger healthcare providers or the expansion of its direct-to-consumer support infrastructure.
See full Safe N Simple company page
